These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8959743)

  • 1. Novel neuropeptide Y processing in human cerebrospinal fluid from depressed patients.
    Ekman R; Juhasz P; Heilig M; Agren H; Costello CE
    Peptides; 1996; 17(7):1107-11. PubMed ID: 8959743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment.
    Wagner L; Björkqvist M; Lundh SH; Wolf R; Börgel A; Schlenzig D; Ludwig HH; Rahfeld JU; Leavitt B; Demuth HU; Petersén Å; von Hörsten S
    J Neurochem; 2016 Jun; 137(5):820-37. PubMed ID: 27016395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing of neuropeptide Y and somatostatin in human cerebrospinal fluid as monitored by radioimmunoassay and mass spectrometry.
    Nilsson C; Westman A; Blennow K; Ekman R
    Peptides; 1998; 19(7):1137-46. PubMed ID: 9786162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
    Nilsson CL; Brinkmalm A; Minthon L; Blennow K; Ekman R
    Peptides; 2001 Dec; 22(12):2105-12. PubMed ID: 11786197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of two-dimensionally separated human cerebrospinal fluid proteins by N-terminal sequencing, matrix-assisted laser desorption/ionization--mass spectrometry, nanoliquid chromatography-electrospray ionization-time of flight-mass spectrometry, and tandem mass spectrometry.
    Raymackers J; Daniels A; De Brabandere V; Missiaen C; Dauwe M; Verhaert P; Vanmechelen E; Meheus L
    Electrophoresis; 2000 Jun; 21(11):2266-83. PubMed ID: 10892737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive release of endogenous neuropeptide Y into cerebrospinal fluid after treatment of spontaneous subarachnoid haemorrhage and its possible impact on self-reported neuropsychological performance - results of a prospective clinical pilot study on good-grade patients.
    Bründl E; Proescholdt M; Schödel P; Bele S; Höhne J; Zeman F; Stoerr EM; Brawanski A; Schebesch KM
    Neurol Res; 2018 Dec; 40(12):1001-1013. PubMed ID: 30213237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls.
    Gjerris A; Widerlöv E; Werdelin L; Ekman R
    J Psychiatry Neurosci; 1992 Mar; 17(1):23-7. PubMed ID: 1349825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of peptide nucleic acid fluorescence in situ hybridization assays with culture-based matrix-assisted laser desorption/ionization-time of flight mass spectrometry for the identification of bacteria and yeasts from blood cultures and cerebrospinal fluid cultures.
    Calderaro A; Martinelli M; Motta F; Larini S; Arcangeletti MC; Medici MC; Chezzi C; De Conto F
    Clin Microbiol Infect; 2014 Aug; 20(8):O468-75. PubMed ID: 24304149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram.
    Nikisch G; Agren H; Eap CB; Czernik A; Baumann P; Mathé AA
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):403-10. PubMed ID: 15784158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
    Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
    J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations.
    Brakch N; Rist B; Beck-Sickinger AG; Goenaga J; Wittek R; Bürger E; Brunner HR; Grouzmann E
    Biochemistry; 1997 Dec; 36(51):16309-20. PubMed ID: 9405066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Instability of side-chain protecting groups during MALDI-TOF mass spectrometry of peptide fragments.
    Schmidt M; Krause E; Beyermann M; Bienert M
    Pept Res; 1995; 8(4):238-42. PubMed ID: 8527878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.
    Heilig M; Zachrisson O; Thorsell A; Ehnvall A; Mottagui-Tabar S; Sjögren M; Asberg M; Ekman R; Wahlestedt C; Agren H
    J Psychiatr Res; 2004; 38(2):113-21. PubMed ID: 14757324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid (CSF) neuropeptide Y- and somatostatin-like immunoreactivities in man.
    Maeda K; Yasuda M; Kaneda H; Maeda S; Yamadori A
    Neuropeptides; 1994 Dec; 27(6):323-32. PubMed ID: 7898640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder.
    Hou C; Jia F; Liu Y; Li L
    Brain Res; 2006 Jun; 1095(1):154-8. PubMed ID: 16713589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid neuropeptide Y levels in major depression and reported childhood trauma.
    Soleimani L; Oquendo MA; Sullivan GM; Mathé AA; Mann JJ
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of electrospray ionization MS/MS and matrix-assisted laser desorption/ionization-time of flight mass spectrometry to structural analysis of the glycosyl-phosphatidylinositol-anchored protein.
    Taguchi R; Hamakawa N; Maekawa N; Ikezawa H
    J Biochem; 1999 Aug; 126(2):421-9. PubMed ID: 10423539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemically-assisted fragmentation combined with multi-dimensional liquid chromatography and matrix-assisted laser desorption/ionization post source decay, matrix-assisted laser desorption/ionization tandem time-of flight or matrix-assisted laser desorption/ionization tandem mass spectrometry for improved sequencing of tryptic peptides.
    Flensburg J; Tangen A; Prieto M; Hellman U; Wadensten H
    Eur J Mass Spectrom (Chichester); 2005; 11(2):169-79. PubMed ID: 16046801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry.
    Gelfanova V; Higgs RE; Dean RA; Holtzman DM; Farlow MR; Siemers ER; Boodhoo A; Qian YW; He X; Jin Z; Fisher DL; Cox KL; Hale JE
    Brief Funct Genomic Proteomic; 2007 Jun; 6(2):149-58. PubMed ID: 17584762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying neuropeptide Y (NPY) as the main stress-related substrate of dipeptidyl peptidase 4 (DPP4) in blood circulation.
    Wagner L; Kaestner F; Wolf R; Stiller H; Heiser U; Manhart S; Hoffmann T; Rahfeld JU; Demuth HU; Rothermundt M; von Hörsten S
    Neuropeptides; 2016 Jun; 57():21-34. PubMed ID: 26988064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.